MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Investigational New Drugs
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

191 results · 1 filter active ·
Results by year
20022025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
191 works in the cohort · of 4,299,418page 1 of 4

Labels cover 1 of 191 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 191 of 191 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

afffundaboutno abstractunlabeled
Phase II trial of DNA methyltransferase 1 inhibition with the antisense oligonucleotide MG98 in patients with metastatic renal carcinoma: A National Cancer Institute of Canada Clinical Trials Group investigational new drug study
Eric Winquist, Jennifer J. Knox, Jean-Pierre M. Ayoub, Nancy Wainman, Gregory K. Reid, Laura Pearce +2 more
2006· article· en· Investigational New Drugs· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
131
citations
affno abstractunlabeled
Phase II trial of vorinostat in advanced melanoma
Naomi B. Haas, Ian Quirt, Sebastién J. Hotte, Elaine McWhirter, R. Polintan, Samuel Litwin +8 more
2014· article· en· Investigational New Drugs· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
70
citations
affno abstractunlabeled
The oncolytic virus, pelareorep, as a novel anticancer agent: a review
Romit Chakrabarty, Hue Tran, Giovanni Selvaggi, Allison Hagerman, Brad Thompson, Matt Coffey
2015· review· en· Investigational New Drugs· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · none
69
citations
afffundno abstractunlabeled
Irinotecan and DNA-PKcs inhibitors synergize in killing of colon cancer cells
David Davidson, Yannick Coulombe, Verónica L. Martínez‐Marignac, Lilian Amrein, Jeremy Grenier, Keira Hodkinson +3 more
2011· article· en· Investigational New Drugs· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
53
citations

How this was built: Screen · Findings · About